Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample

Quality of Life Research

Volumn 7, Issue 2, 1998, Pages 127-134

  Leidy, N K ^a   Coughlin, C ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b UNITEDHEALTH GROUP   (United States)

Author keywords

Asthma; Measurement; Methodology; Psychometrics; Quality of life

Indexed keywords

ADULT; ARTICLE; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PERFORMANCE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; UNITED STATES;

ADULT; ANALYSIS OF VARIANCE; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 0031951564     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008853325724     Document Type: Article

References (40)

1. Juniper EF, Guyatt GH, Epstein RS, Ferry PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
2. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992; 45: 461-472.
3. Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. Psychosomat Res 1991; 35: 99-110.
4. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. Am Rev Respirat Dis 1992; 45: 1321-1327.
5. Perpina M, Belloch A, Pascual LM, de Diego A, Compte L. Calidad de vida en el asma: validacion del cuestionario AQLQ para su utilizacion en poblacion espa∼nola (The quality of life in asthma: an evaluation of the AQLQ questionnaire for its use on a Spanish population. Asthma Quality of Life Questionnaire). Arch Bronconeumol 1995; 31(5): 211-218.
6. Rutten-van Mölken MP, Custers F, van Doorslaer EK et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respirat J 1995; 8(6): 888-898.
7. Revicki D, Sorensen S, Leidy NK, Togias A. Integrating patient preferences into health outcomes assessment: the Asthma-Symptom Utility Index. Am J Respirat Crit Care Med 1996; 153(4): A549.
8. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respirat Dis 1993; 147: 832-838.
9. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.
10. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respirat Crit Care Med 1995; 151: 66-70.
11. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respirat Dis 1993; 148: 675-681.
12. Jones P. Issues concerning health-related quality of life in COPD. Chest 1995; 107(5): 187S-193S.
13. Leidy NK State of the science: functional performance in people with chronic obstructive pulmonary disease. Image: J Nurs Schol 1995; 27(1): 23-34.
14. Stewart AL, Hays RD, Ware JE. The MOS short term general health survey. Med Care 1988; 24: 724-32.
15. Bergner M, Bobbit RA, Carer WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
16. Rowe BH, Oxman AD. An assessment of the sensibility of a quality-of-life instrument. Am J Emerg Med 1993; 11: 374-380.
17. Barber BL, Santanello NC, Epstein RS. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Qual Life Res 1996; 5: 117-122.
18. Israel E, Cohn J, Dubé L, Drazen JM. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma: randomized controlled trial. JAMA 1996; 275: 931-936.
19. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35-46.
20. Feeny DH, Torrance GW, Furlong W. Health Utilities Index (HUI). In: Spilker B. ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Raven Press, 1996; 239-252.
21. Torrance GW, Furlong W, Feeny D, Boyle MH. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7: 503-520.
22. Torrance GW, Zhang Y, Feeny DH, Furlong W, Barr R. Multi-attribute Preference Functions for a Comprehensive Health Status Classification System. Hamilton, Ontario: Centre for Health Economics and Policy Analysis, McMaster University, 1992.
23. Nunnally J. Psychometric Theory, 2nd edn. New York: McGraw-Hill, 1978.
24. Malo JL, Boulet LP, Dewitte JD, et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol 1993; 91: 1121-1127.
25. Gibson PG, Talbot PI, Toneguzzi RC, Population Medical Group 91C. Self-management, autonomy and quality of life in asthma. Chest 1995; 107: 1003-1008
26. Hindi-Alexander MC, Scherer YK, Opila DA et al. Asthma and the use of CNS depressants: gender differences. J Asthma 1992 24(4): 259-264.
27. Quirk FH, Jones PW. Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors. Clin Sci. 1990; 79: 17-21.
28. Quirk FH, Baveystock CM, Wilson R, Jones PW. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respirat J 1991; 4: 167-171.
29. Leidy NK, Traver GA. Psychophysiologic factors contributing to functional performance in people with COPD: are there gender differences? Res Nurs Health 1995; 18: 535-546.
30. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey-Manual and Interpretation Guide. Boston, MA: Nimrod Press, 1993.
31. Wiklund IK. Hypertension. In Spilker B ed. Quality of Life and Pharmacoeconomics in Clinical Trial, 2nd edn. Philadelphia: Lippincott-Raven, 1996; 893-902.
32. Mutchler JE, Burr JA. Racial differences in health and health care service utilization in later life: the effect of socioeconomic status. J Health Soc Behav 1991; 32: 342-356.
33. Robert S, House JS. SES differentials in health by age and alternative indicators of SES. J Aging Health 1996; 8: 359-388.
34. Cella DF, Lloyd SR, Wright BD. Cross-cultural instrument equating: current research and future directions. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven, 1996; 707-715.
35. Noro A, Aro S. Health-related quality of life among the least dependent institutional elderly compared with the non-institutional elderly population. Qual Life Res 1996; 5: 355-366.
36. Hopton JL, Howie JG, Porter AM. Social indicators of health needs for general practice: a simpler approach. Br J Gen Pract 1992; 42: 236-240.
37. Haas JS, Cleary PD, Guadagnoli E, Fanta C, Epstein AM. The impact of socioeconomic status on the intensity of ambulatory treatment and health outcomes after hospital discharge for adults with asthma. J Gen Intern Med 1994; 9: 121-126.
38. Player R, Richards JM, Kohler CL, Woodby LL, Brooks CM, Bailey WC. Scale for assessing functional impairment in adults with asthma. J Asthma 1994; 31: 437-444.
39. Schwartz J, Gold D, Dockery DW, Weiss ST, Speizer FE. Predictors and persistent wheeze in a national sample of children in the United States: association with social class, perinatal events, and race. Am Rev Respirat Dis 1990; 142: 555-562.
40. Weiss KB, Wagener DK. Changing patterns of asthma mortality: identifying target populations at high risk. JAMA 1990; 264(13): 1683-1687.